Its called BPC-157, and the vascular angle is central to its pitch
FDA's Official Reasons: Lack of Clinical Trials: The FDA emphasizes the need for extensive, controlled clinical trials, which are currently lacking
Although not as well-known as weight-loss peptides like GLP-1s like semaglutide and tirzepatide, 5-Amino-1MQ is becoming one of the most talked-about compounds in functional medicine for its similar role in weight loss and metabolic support
Are at high risk (e.g., older adults, people with darker skin, those with limited sun exposure)
While formal pharmacokinetic parameters (Cmax, AUC, t1/2) have not been published in peer-reviewed literature for oral dosing in humans, its low molecular weight (173 Da), positive charge, and water solubility support intestinal absorption